Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024Pharmacy EducationOpen Access

Pharmacophore-based virtual screening of bioactive peptides as dipeptidyl peptidase 4 inhibitor for type 2 diabetes mellitus drug candidates

View Full Paper
Ask AI
Bookmark
Share

Authors

FMFauzan Zein MuttaqinMRMuhamad Iqbal RhamadiantoGJGarnadi Jafar

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Muttaqin et al. (2024) studied this question.

synapsesocial.com/papers/68e712b5b6db64358768b976https://doi.org/10.46542/pe.2024.242.145151
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study2024 · 23 citations
  2. 2The Theoretical Substantiation of the Targeted Search for New DPP4 Inhibitors. Computational Studies of Potential Candidates2024
  3. 3Characterization of multi-targeted insulin-mimetic antidiabetic peptides using in silico approaches2025
  4. 4IN SILICO DESIGN, 3D QSAR, PHARMACOPHORE MODELLING, AND MOLECULAR DOCKING STUDIES OF NOVEL ANTIDIABETIC AGENTS2026
  5. 5Discovery of novel aminomethyl-piperidone derivatives as dipeptidyl peptidase-4 inhibitors2026